We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
191 hedge funds and large institutions have $1.71B invested in Rocket Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
258% more call options, than puts
Call options by funds: $4.96M | Put options by funds: $1.39M
68% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 19
26% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 53
7% more funds holding
Funds holding: 178 → 191 (+13)
1.35% more ownership
Funds ownership: 100.51% → 101.86% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
13% less capital invested
Capital invested by funds: $1.96B → $1.71B (-$255M)
Holders
191
Holders Change
+13
Holders Change %
+7.3%
% of All Funds
2.74%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
67
Reduced
53
Closed
19
Calls
$4.96M
Puts
$1.39M
Net Calls
+$3.58M
Net Calls Change
+$1.56M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$42.7M |
| 2 |
Millennium Management
New York
|
+$22.5M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$21.8M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$7.12M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.6M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$20.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$17M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$13.7M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.19M |
